Literature DB >> 9072380

Animal models of vascular dementia with emphasis on stroke-prone spontaneously hypertensive rats.

H Saito1, H Togashi, M Yoshioka, N Nakamura, M Minami, H Parvez.   

Abstract

1. Two experimental models designed to reflect different aspects of vascular dementia (rats with cerebrovascular occlusion and rats with cerebral embolization) and stroke-prone spontaneously hypertensive rats (SHRSP) have been evaluated. The focus was on SHRSP as a model for vascular dementia. 2. Neuropathological data revealed that the cerebrovascular disorder in SHRSP was associated with lesions in their brains similar to those seen in typical human cases of multiple cerebral infarction. 3. SHRSP that died from cerebral infarction exhibited behavioural changes, including increased activity and disrupted circadian rhythms, which might correspond to the state of delirium observed in patients with dementia. 4. SHRSP displayed cognitive impairments in a step-through passive avoidance task. 5. When compared to age-matched Wistar Kyoto (WKY) rats, both conscious and anaesthetized SHRSP had significantly decreased cerebral spinal fluid (CSF) levels of acetylcholine (ACh). 6. These findings suggest that the SHRSP might serve as a suitable animal model for vascular dementia in humans caused by cerebrovascular lesions.

Entities:  

Mesh:

Year:  1995        PMID: 9072380     DOI: 10.1111/j.1440-1681.1995.tb02906.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol Suppl        ISSN: 0143-9294


  11 in total

Review 1.  Use of Cholinesterase Inhibitors in Non-Alzheimer's Dementias.

Authors:  Paul Noufi; Rita Khoury; Sajeeka Jeyakumar; George T Grossberg
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

2.  Regional cerebral blood flow and arterial blood volume and their reactivity to hypercapnia in hypertensive and normotensive rats.

Authors:  Tae Kim; J Richard Jennings; Seong-Gi Kim
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-20       Impact factor: 6.200

3.  Inhibited Expression of α4β2 Nicotinic Acetylcholine Receptor in Blood Leukocytes of Chinese Patients with Vascular Dementia and in Blood Leukocytes as Well as the Hippocampus of Brain from Ischemic Rats.

Authors:  Yan Xiao; Liang Zhao; Shi-Xiang Kuang; Zhi-Zhong Guan
Journal:  Cell Mol Neurobiol       Date:  2016-02-08       Impact factor: 5.046

Review 4.  Management of mixed dementia.

Authors:  Dina Zekry; Gabriel Gold
Journal:  Drugs Aging       Date:  2010-09-01       Impact factor: 3.923

5.  Correlations between cholinesterase activity and cognitive scores in post-ischemic rats and patients with vascular dementia.

Authors:  Yan Xiao; Zhi-Zhong Guan; Chang-Xue Wu; Yi Li; Shi-Xiang Kuang; Jin-Jing Pei
Journal:  Cell Mol Neurobiol       Date:  2011-11-17       Impact factor: 5.046

Review 6.  Cholinesterase inhibitors and vascular dementia: another string to their bow?

Authors:  Roger Bullock
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

7.  Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.

Authors:  Gary Small; Timo Erkinjuntti; Alexander Kurz; Sean Lilienfeld
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  Endotoxin-induced changes in human working and declarative memory associate with cleavage of plasma "readthrough" acetylcholinesterase.

Authors:  Osnat Cohen; Abraham Reichenberg; Chava Perry; Dalia Ginzberg; Thomas Pollmächer; Hermona Soreq; Raz Yirmiya
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 9.  Hypertension and Its Impact on Stroke Recovery: From a Vascular to a Parenchymal Overview.

Authors:  Benjamin Maïer; Nathalie Kubis
Journal:  Neural Plast       Date:  2019-10-14       Impact factor: 3.599

Review 10.  Multi-Infarct Dementia: A Historical Perspective.

Authors:  Erin McKay; Scott E Counts
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2017-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.